Experienced in Menopause

Dr. Scott E. Eder

Obstetrics and Gynecology
2 Belleview Ter, 
Princeton, NJ 
Experienced in Menopause
2 Belleview Ter, 
Princeton, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Scott Eder is an Obstetrics and Gynecologist in Princeton, New Jersey. Dr. Eder is rated as an Experienced provider by MediFind in the treatment of Menopause. His top areas of expertise are Vulvovaginitis, Menopause, Uterine Fibroids, and Angiomyoma.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Menopause.

Specialties
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in NJ
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

2 Belleview Ter, Princeton, NJ 08540

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Study to Assess the Efficacy and Safety of Linzagolix in Subjects With Moderate to Severe Endometriosis-associated Pain.
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Study to Assess the Efficacy and Safety of Linzagolix in Subjects With Moderate to Severe Endometriosis-associated Pain.
Enrollment Status: Completed
Publish Date: April 02, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Descriptive, Prospective, Multi-country, Multicentre Study to Assess Performance of Genital Herpes Simplex Virus-2 (HSV-2) Related Disease Endpoints Based on Patient-reported Health Outcomes, Self-swabbing Collected Via Decentralised Approach in Patients ≥ 18 Years of Age in the United States and Europe.
A Descriptive, Prospective, Multi-country, Multicentre Study to Assess Performance of Genital Herpes Simplex Virus-2 (HSV-2) Related Disease Endpoints Based on Patient-reported Health Outcomes, Self-swabbing Collected Via Decentralised Approach in Patients ≥ 18 Years of Age in the United States and Europe.
Enrollment Status: Completed
Publish Date: March 07, 2025
Intervention Type: Procedure
A Phase 3 Multi-Center, Double-Blind, Placebo-Controlled, Randomized Study of DARE-BV1 in the Treatment of Bacterial Vaginosis
A Phase 3 Multi-Center, Double-Blind, Placebo-Controlled, Randomized Study of DARE-BV1 in the Treatment of Bacterial Vaginosis
Enrollment Status: Completed
Publish Date: December 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
Enrollment Status: Completed
Publish Date: August 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Enrollment Status: Completed
Publish Date: August 04, 2020
Intervention Type: Drug
Study Phase: Phase 3
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Enrollment Status: Completed
Publish Date: July 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

9 Total Publications

Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 12, 2021
Similar Doctors
Elite in Menopause
Dr. Peter F. Schnatz
Obstetrics and Gynecology
Elite in Menopause
Dr. Peter F. Schnatz
Obstetrics and Gynecology

Lehigh Valley Physician Group

1611 Pond Rd, Suite 300, 
Allentown, PA 
 (47.3 miles away)
610-398-9770
Languages Spoken:
English
See accepted insurances

Peter Schnatz is an Obstetrics and Gynecologist in Allentown, Pennsylvania. Dr. Schnatz is rated as a Distinguished provider by MediFind in the treatment of Menopause. His top areas of expertise are Menopause, Postmenopausal Osteoporosis, Premature Ovarian Failure, Hormone Replacement Therapy (HRT), and Oophorectomy.

Elite in Menopause
Dr. Gloria A. Bachmann
Obstetrics and Gynecology
Elite in Menopause
Dr. Gloria A. Bachmann
Obstetrics and Gynecology

Rutgers Health-Rwj Scleroderma Program

125 Paterson St, 
New Brunswick, NJ 
 (17.7 miles away)
732-235-6600
Languages Spoken:
English
See accepted insurances

Gloria Bachmann is an Obstetrics and Gynecologist in New Brunswick, New Jersey. Dr. Bachmann is rated as a Distinguished provider by MediFind in the treatment of Menopause. Her top areas of expertise are Menopause, Vulvodynia, Postmenopausal Osteoporosis, Hormone Replacement Therapy (HRT), and Intrauterine Device Insertion.

Elite in Menopause
Dr. Rogerio A. Lobo
Reproductive Medicine | Obstetrics and Gynecology
Elite in Menopause
Dr. Rogerio A. Lobo
Reproductive Medicine | Obstetrics and Gynecology

Trustees Of Columbia University In The City Of New York

51 W 51st St, 
New York, NY 
 (48.4 miles away)
212-326-5705
Languages Spoken:
English
See accepted insurances

Rogerio Lobo is a Reproductive Medicine specialist and an Obstetrics and Gynecologist in New York, New York. Dr. Lobo is rated as a Distinguished provider by MediFind in the treatment of Menopause. His top areas of expertise are Menopause, Ovarian Overproduction of Androgens, Polycystic Ovary Syndrome, Hormone Replacement Therapy (HRT), and Hysterectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Eder's expertise for a condition
ConditionClose
        View All 12 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile